National Weight-Loss Study Open At Moores UCSD Cancer Center

 

April 10, 2007  |  

Nutrition experts at the Moores UCSD Cancer Center and Scripps Clinic in Del Mar are seeking obese men and women to participate in a research study for weight loss employing an investigational combination drug therapy and behavioral modification. Study participants will receive at no cost medical evaluations, individualized diet and exercise programs, weekly nutritional and lifestyle group sessions, and the investigational study drugs or placebo.

The UCSD and Scripps collaboration represents one of nine study sites in the U.S. The study drugs have been shown to be safe and effective in preliminary clinical trials and are FDA approved for other conditions but not yet for weight loss.

To be eligible for this study, an individual must be obese, a non-smoker for at least six months, between 18 and 65 years of age, non-diabetic and in overall good health.

For further information, call the clinical research coordinator at UCSD Moores Cancer Center, 858-822-2779.

# # #

Media Contact:  Nancy Stringer,  619-543-6163, nstringer@ucsd.edu




Media Contact

Share This Article


Related News

5/22/2017
On Sunday, May 21, the Student Run Free Clinic Project at UC San Diego was recognized by the American Psychiatric Association (APA) for excellence in caring for the community. For two decades, the Stu ...
5/22/2017
Liver cirrhosis is the 12th leading cause of mortality worldwide and approximately half of those deaths are due to alcohol abuse. Yet apart from alcohol abstinence, there are no specific treatments to ...
5/21/2017
Among 12- to 17-year-olds who have never used tobacco products, nearly half were considered receptive to tobacco marketing if they were able to recall or liked at least one advertisement, report resea ...
5/11/2017
Researchers at University of California San Diego School of Medicine, with collaborators across the nation, have determined that magnetic resonance elastography (MRE) can be an accurate, non-invasive ...



Follow Us